Share on StockTwits

Smith & Nephew plc (NYSE:SNN) was downgraded by stock analysts at Jefferies Group from a “buy” rating to a “hold” rating in a report issued on Tuesday, reports.

Other equities research analysts have also recently issued reports about the stock. Analysts at Berenberg Bank reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Tuesday, August 26th. Separately, analysts at Morgan Stanley downgraded shares of Smith & Nephew plc from an “overweight” rating to an “equal weight” rating in a research note on Friday, August 15th. Finally, analysts at Panmure Gordon reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Monday, August 4th. Ten investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Smith & Nephew plc currently has an average rating of “Hold” and a consensus price target of $97.00.

Smith & Nephew plc (NYSE:SNN) traded down 0.30% during mid-day trading on Tuesday, hitting $86.64. The stock had a trading volume of 52,655 shares. Smith & Nephew plc has a 52 week low of $58.93 and a 52 week high of $100.90. The stock has a 50-day moving average of $87.49 and a 200-day moving average of $82.69. The company has a market cap of $15.491 billion and a price-to-earnings ratio of 29.91.

Smith & Nephew plc (NYSE:SNN) last released its earnings data on Friday, August 1st. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.94 by $0.08. On average, analysts predict that Smith & Nephew plc will post $4.21 earnings per share for the current fiscal year.

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.

The Fly On The Wall

Receive News & Ratings for Smith & Nephew plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.